Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:1
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (75.0%)Phase 1
1 (25.0%)Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects
- First Posted Date
- 2014-04-02
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- UCB Korea Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02101710
- Locations
- 🇰🇷
1, Jeollabuk-do, Korea, Republic of
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- UCB Korea Co., Ltd.
- Target Recruit Count
- 380
- Registration Number
- NCT01523301
- Locations
- 🇰🇷
03, Ansan, Korea, Republic of
🇰🇷19, Anyang, Korea, Republic of
🇰🇷08, Busan, Korea, Republic of
Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- Korea UCB Co., Ltd.
- Target Recruit Count
- 353
- Registration Number
- NCT01498822
- Locations
- 🇰🇷
05, Busan, Korea, Republic of
🇰🇷10, Busan, Korea, Republic of
🇰🇷16, Busan, Korea, Republic of
Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- UCB Korea Co., Ltd.
- Target Recruit Count
- 343
- Registration Number
- NCT01229735
- Locations
- 🇰🇷
14, Busan, Korea, Republic of
🇰🇷21, Busan, Korea, Republic of
🇰🇷8, Busan, Korea, Republic of
News
No news found